We know that there are persistent myths about cannabis among opponents of reform, from the gateway drug theory to demotivational syndrome. But there are also myths among cannabis smokers.
“The numbers show us that the current Polish drug policy is not working,” says Adam Stasiak from the Polish Drug Policy Network.
Are you a cannabis user in Italy as a student, on business, or on vacation? Here is a guide we think you should read to avoid problems with the law.
The New Zealand Drug Foundation has been in the forefront of drug policy debates in New Zealand for more than 25 years. We interviewed its director, Ross Bell, about the chances of reforming drug laws in his country.
The Catalonian parliament has recently adopted a new law to regulate the cannabis market. We interviewed Òscar Parés, the deputy director of the International Center for Ethnobotanical Education, Research & Service to learn more about the cannabis reconquista movement in Spain.
Although it was without much fanfare that the European Commission, in July 2017, published the new Action Plan on Drugs (2017-2020), the drug policy community should celebrate it as a great achievement both for its progressive content and for the meaningful involvement of civil society in its preparation. [There is a Polish, Estonian, Hungarian and Serbian translation of this article!]
While the federal government of Germany does not dare to change cannabis laws, cities like Berlin and Düsseldorf are taking over the lead in reform. We interviewed Georg Wurth, the chairman of the German Cannabis Association about the situation.
In February 2016, Macedonia legalised medicinal cannabis but the law is far from ideal. Drugreporter’s Macedonian partner, Healthy Options Project Skopje – HOPS – carried out an analysis of the law. Read their key remarks and recommendations presented by Vlatko Dekov.